Legend Biotech GAAP EPS of -$0.15 beats by $0.02, revenue of $305.1M misses by $1.42M
Source: SeekingAlpha
2026-05-12 07:05:43 ET
More on Legend Biotech
- Legend Biotech: Undervalued Leader In The CAR-T Race
- Legend Biotech Corporation (LEGN) Q4 2025 Earnings Call Transcript
- Legend Biotech Corporation 2025 Q4 - Results - Earnings Call Presentation
- Legend Biotech Q1 2026 Earnings Preview
- Healthcare quant check: RLAY and TNGX lead Seeking Alpha’s top picks ahead of Q1 earnings
Read the full article on Seeking Alpha
For further details see:
Legend Biotech GAAP EPS of -$0.15 beats by $0.02, revenue of $305.1M misses by $1.42M
Legend Biotech Corporation
NASDAQ: LEGN
LEGN Trading
31.03% G/L:
$32.8618 Last:
8,520,944 Volume:
$25.37 Open:
LEGN Latest News
June 02, 2026 09:30:00 am
Legend Biotech Announces Late-Breaking Oral Presentation at EHA 2026 Showcasing Initial Phase 1 In Vivo CAR-T Data with LB2501 in Non-Hodgkin Lymphoma (NHL)
LEGN Stock Data
$3,309,357,827
166,569,786
N/A
63
N/A
Biotechnology & Life Sciences
Healthcare
US
Somerset
